Detalhe da pesquisa
1.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet
; 397(10275): 671-681, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545094
2.
Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways.
Genes Immun
; 22(1): 56-63, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864033
3.
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Lancet
; 396(10255): 887-897, 2020 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896291
4.
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Front Immunol
; 14: 1228461, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600800
5.
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.
Lancet Reg Health Eur
; 11: 100241, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746910
6.
Stimulation of Dectin-1 and Dectin-2 during Parenteral Immunization, but Not Mincle, Induces Secretory IgA in Intestinal Mucosa.
J Immunol Res
; 2018: 3835720, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29725603
7.
Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis.
Biochimie
; 113: 10-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25796214